BioPharma Pharma & Biopharma Manufacturing
WuXi Biologics Begins Construction of One of the World’s Largest Modular Biologics Drug Product Facilities in Singapore
Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse ...
July 30, 2025 | News
AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in th...
July 22, 2025 | News
WuXi Biologics China PFS Site Clears FDA Inspection
WuXi Biologics’ pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-qu...
July 22, 2025 | News
Thermo Fisher to Acquire Sanofi’s Ridgefield Site, Expanding U.S. Steriles Manufacturing Capacity
Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additional ...
July 17, 2025 | News
Bio Investments Group and IVI Forge Strategic Alliance to Accelerate Vaccine Self-Reliance in Africa and the Middle East
The Bio Investments Group AG (BIG), a leading global healthcare-technology transfer platform, and the International Vaccine Institute (IVI), an internation...
July 14, 2025 | News
Sartorius Stedim Biotech and Sensible Biotechnologies Forge Alliance to Scale Cell-Based mRNA Manufacturing
Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, and Sensible Biotechnologies, a pioneer in cell-based design a...
July 11, 2025 | News
Univercells Technologies and Repligen Collaborate to Advance Real-Time Monitoring in Viral Vector and Vaccine Manufacturing
Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced a collaboration with Repli...
July 10, 2025 | News
Unlocking Solubility as Lubrizol's Excipients Power the Next Generation of Drug Delivery
With up to 90% of new chemical entities suffering from poor water solubility, pharmaceutical innovators are under pressure to reformulate for eff...
July 09, 2025 | Interview
WuXi AppTec Completes RMB1 Billion A-Share Buyback and HKD2.5 Billion H-Share Acquisition to Drive Shareholder and Talent Value
WuXi AppTec Co., Ltd, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and ...
July 09, 2025 | News
Sirtex Secures FDA Approval for SIR-Spheres® Y-90 in Treating Unresectable Hepatocellular Carcinoma
Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food and Drug Administration (F...
July 08, 2025 | News
Japanese Life Sciences Delegation Strengthens Collaboration with North Carolina’s Innovation Ecosystem
A high-level Japanese delegation specializing in life sciences concluded a three-day visit to North Carolina (June 24–26), further strengthening ties...
July 07, 2025 | News
Biosynth Expands GMP Bioconjugation Facility in Berlin to Advance Next-Generation Therapeutics
Biosynth, a leading developer and supplier of critical raw materials and services for life sciences and diagnostics, is pleased to announce the openi...
July 07, 2025 | News
Switzerland’s RDP Pharma and Singapore’s A*STAR EDDC Join Forces to Develop Precision Autoimmune Therapies
RDP Pharma AG, a Swiss biotechnology company focused on next-generation protein degradation therapeutics, and the Experimental Drug Development...
July 02, 2025 | News
Takara Bio Europe Partners with MACHEREY-NAGEL to Distribute Bioanalysis Portfolio Across Europe
Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and...
July 02, 2025 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
